Home > > Middle East & Africa And Global ePharmacy Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa ePharmacy market was valued at $16,701.2 Million in 2023, and is projected to reach $38,141.4 Million by 2030 growing at a CAGR of 12.57% from 2024 to 2030. Cold & Flu segment is expected to be the highest contributor to this market, with $7,139.6 Million in 2023, and is anticipated to reach $16,506.8 by 2030, registering a CAGR of 12.77%. Cold & Flu and Vitamins segments collectively expected to account for about 69.4% share of the Middle East & Africa ePharmacy market in 2023, with the former constituting around 42.7% share. Cold & Flu and Vitamins segments are expected to witness significant growth rates at a CAGR of 12.77% and 12.67% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 69.4% in the overall Middle East & Africa ePharmacy market in 2023, and is anticipated to reach 70.1% by 2030. Therapy Area Weight Loss Vitamins Cold & Flu Dermatology Other Therapy Areas Product OTC Medicine Prescription Medicine BY REGION North America U.s. Canada Mexico Europe Germany France U.k. Italy Spain Russia Rest of Europe Asia China India Japan Australia South Korea Rest of Asia Middle East & Africa Brazil South Africa GCC Rest of MENA